Back
New York Times Vs. Cidara Therapeutics Industry Stock Comparison
Buy
73
NYT
New York Times
Last Price:
$60.64
Seasonality Move:
-1.02%
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$63.02
Seasonality Move:
2.01%
Buy
73
New York Times (NYT)
is a Buy
Is New York Times a Buy, Sell or Hold?
-
The current New York Times [NYT] share price is $58.01. The Score for NYT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NYT Stock Price Chart
What is New York Times's stock price today?
-
The New York Times share price today is $58.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $62.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
NYT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.61 | Buy |
Relative Strength Index (14 RSI): | 60.3 | Buy |
Chaikin Money Flow: | 953834 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.08 - 57.12) | Buy |
Bollinger Bands (100): | (50.11 - 56.41) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.72 | Buy |
Relative Strength Index (14 RSI): | 66.1 | Buy |
Chaikin Money Flow: | -71329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.74 - 63.84) | Buy |
Bollinger Bands (100): | (16.87 - 51.01) | Buy |
NYT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.61 | Buy |
20-day SMA: | 54.31 | Buy |
50-day SMA: | 55.14 | Buy |
200-day SMA: | 52.86 | Buy |
8-day EMA: | 53.41 | Buy |
20-day EMA: | 37.43 | Buy |
50-day EMA: | 19.8 | Buy |
200-day EMA: | 5.77 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.11 | Sell |
20-day SMA: | 61.15 | Buy |
50-day SMA: | 46.89 | Buy |
200-day SMA: | 27.08 | Buy |
8-day EMA: | 58.14 | Buy |
20-day EMA: | 41.46 | Buy |
50-day EMA: | 22.13 | Buy |
200-day EMA: | 6.48 | Buy |
New York Times Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
New York Times Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |